Advertisement

Biocon Pharma gets GMP compliance certificate from UK's health regulator MHRA for Bengaluru facility

The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection

Advertisement
|Apr 12, 2021, 19:50:29 IST

New Delhi: Biotechnology firm Biocon on Monday said its subsidiary Biocon Pharma has received Good Manufacturing Practice (GMP) compliance certificate from UK's health regulator MHRA for its Bengaluru facility."Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Medicines and Healthcare products Regulatory Agency (MHRA), the United Kingdom (UK), for its manufacturing facility at Biocon Park in Bengaluru," Biocon said in a regulatory filing.The certificate, which includes manufacturing and packaging of tablets and capsules in the non-potent and potent blocks of the facility, was issued based on a remote inspection in the week of 22 March, 2021, in the wake of travel restrictions amidst COVID-19, the company added.Shares of Biocon were trading 0.08 percent lower at Rs 419.95 apiece on BSE.

Advertisement
Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Apr 12, 2021, 19:50:29 IST
Advertisement
Advertisement
Trending Stories

Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs

Brain tumours are frequently mistaken for common headaches, stress or age-related cognitive changes. Doctors say recognising warning signs early and adopting a brain-healthy lifestyle can improve outcomes and reduce the risk of long-term neurological complications.
2 min read
Advertisement
Advertisement
Up Next